Clal Insurance’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-45,000
| Closed | -$625K | – | 140 |
|
|
2024
Q1 | $625K | Hold |
45,000
| – | – | 0.01% | 107 |
|
|
2023
Q4 | $642K | Hold |
45,000
| – | – | 0.01% | 100 |
|
|
2023
Q3 | $696K | Sell |
45,000
-2,733,558
| -98% | -$42.3M | 0.01% | 100 |
|
|
2023
Q2 | $43.7M | Sell |
2,778,558
-1,586,942
| -36% | -$24.9M | 0.52% | 51 |
|
|
2023
Q1 | $71.9M | Hold |
4,365,500
| – | – | 1.08% | 28 |
|
|
2022
Q4 | $68.1M | Buy |
4,365,500
+25,000
| +0.6% | +$390K | 1.02% | 33 |
|
|
2022
Q3 | $56.3M | Buy |
4,340,500
+2,600,000
| +149% | +$33.7M | 0.77% | 45 |
|
|
2022
Q2 | $24.4M | Buy |
+1,740,500
| New | +$24.4M | 0.33% | 68 |
|